Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


suck pdf from google scholar
unlimited free pdf from europmc34861051    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

Nephropedia Template TP Text

Twit Text FOAVip

Twit Text #

English Wikipedia

  • High CD4-to-CD8 ratio identifies an at-risk population susceptible to lethal COVID-19 #MMPMID34861051
  • De Zuani M; Laznickova P; Tomaskova V; Dvoncova M; Forte G; Stokin GB; Sramek V; Helan M; Fric J
  • Scand J Immunol 2022[Mar]; 95 (3): e13125 PMID34861051show ga
  • Around half of people with severe COVID-19 requiring intensive care unit (ICU) treatment will survive, but it is unclear how the immune response to SARS-CoV-2 differs between ICU patients that recover and those that do not. We conducted whole-blood immunophenotyping of COVID-19 patients upon admission to ICU and during their treatment and uncovered marked differences in their circulating immune cell subsets. At admission, patients who later succumbed to COVID-19 had significantly lower frequencies of all memory CD8+ T cell subsets, resulting in increased CD4-to-CD8 T cell and neutrophil-to-CD8 T cell ratios. ROC and Kaplan-Meier analyses demonstrated that both CD4-to-CD8 and neutrophil-to-CD8 ratios at admission were strong predictors of in-ICU mortality. Therefore, we propose the use of the CD4-to-CD8 T cell ratio as a marker for the early identification of those individuals likely to require enhanced monitoring and/or pro-active intervention in ICU.
  • |Aged[MESH]
  • |CD4-CD8 Ratio/methods[MESH]
  • |CD4-Positive T-Lymphocytes/*immunology[MESH]
  • |CD8-Positive T-Lymphocytes/*immunology[MESH]
  • |COVID-19/*immunology[MESH]
  • |Female[MESH]
  • |Humans[MESH]
  • |Immunophenotyping/methods[MESH]
  • |Intensive Care Units[MESH]
  • |Lymphocyte Count/methods[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |Prospective Studies[MESH]
  • |SARS-CoV-2/immunology[MESH]

  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    e13125 3.95 2022